phenoxybenzamine has been researched along with mdl 100907 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adamik, A; Telegdy, G | 1 |
Cao, L; Chen, J; Chen, X; Lou, Z; Qing, J; Rao, Z; Wang, Y; Yang, Y | 1 |
2 other study(ies) available for phenoxybenzamine and mdl 100907
Article | Year |
---|---|
Neurotransmitter-mediated anxiogenic action of PACAP-38 in rats.
Topics: Adrenergic Antagonists; Adrenergic beta-Antagonists; Animals; Anxiety; Arginine; Atropine; Bicuculline; Dopamine Antagonists; Exploratory Behavior; Haloperidol; Male; Maze Learning; Methysergide; Muscarinic Antagonists; Naloxone; Narcotic Antagonists; Neurotransmitter Agents; Nitroso Compounds; Peptide Fragments; Phenoxybenzamine; Pituitary Adenylate Cyclase-Activating Polypeptide; Propranolol; Rats; Rats, Wistar; Receptors, GABA; Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide; Serotonin 5-HT2 Receptor Antagonists | 2015 |
Identification of serotonin 2A receptor as a novel HCV entry factor by a chemical biology strategy.
Topics: Animals; Antiviral Agents; Claudin-1; HEK293 Cells; Hepacivirus; Hepatitis C; Hepatocytes; Humans; Mice; Phenoxybenzamine; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists; Virus Internalization | 2019 |